Martin Madaus

Martin Madaus

Net worth: 2 M $ as of 31/05/2026

66 year
Health Technology
Commercial Services
Health Services

Profile

Dr. Martin D.
Madaus
is an Independent Director at Azenta, Inc., a Chairman at Repligen Corp.
and an Executive Chairman at Emulate, Inc. He is on the Board of Directors at Azenta, Inc., Unchained Labs LLC, Candela Medical, Inc., Candela Corp., Massachusetts High Technology Council, Inc., Syntis Bio, Inc. and Ultivue, Inc. Dr. Madaus was previously employed as an Independent Director by Hologic, Inc., an Independent Director by Standard BioTools, Inc., a Chief Operations Officer by Sherlock Biosciences, Inc., a Chairman & Chief Executive Officer by Ortho-Clinical Diagnostics, Inc., an Independent Director by Covidien Ltd., an Independent Director by Mettler-Toledo International, Inc., a Chairman, President & Chief Executive Officer by Millipore Corp., a Chairman, President & Chief Executive Officer by Millipore SA/NV, a President & Chief Executive Officer by Roche Diagnostics Corp., a Chairman & Chief Executive Officer by Ortho-Clinical Diagnostics, and a Vice President-Business Development by Roche Molecular Systems, Inc. He also served on the board at Quanterix Corp., Analytical Life Science & Diagnostics Association, Massachusetts Technology Collaborative, New England Healthcare Institute, Pharmaceutical Product Development LLC, Predictive Biosciences, Inc. and Young Men's Christian Association of Greater Boston, Inc. He received his doctorate degree from Ludwig-Maximilians-Universität München and a doctorate degree from The University of Veterinary Medicine Hanover.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
14/05/2026 8,392 ( 0.01% ) 1 M $ 31/05/2026
02/01/2025 291,541 ( 0.63% ) 892 115 $ 31/05/2026
05/02/2026 7,405 ( 0.02% ) 169 426 $ 31/05/2026

Martin Madaus active positions

CompaniesPositionStart
CANDELA MEDICAL, INC. Director/Board Member 01/05/2018
REPLIGEN CORPORATION Chairman 13/03/2026
AZENTA, INC. Director/Board Member 30/01/2024
Director/Board Member -
Director/Board Member -
Director/Board Member 01/07/2021
Director/Board Member -
Director/Board Member -
Chairman 19/03/2020

Former positions of Martin Madaus

CompaniesPositionEnd
░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░░░░ ░░░░░░░░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
See the detail of Martin Madaus's experience

Training of Martin Madaus

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

68

1st degree connections

29

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies29

Health Technology

Health Technology

Commercial Services

Health Technology

Health Services

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Technology Services

Health Technology

Commercial Services

Health Services

Commercial Services

Health Services

Commercial Services

Electronic Technology

Analytical Life Science & Diagnostics Association

Health Technology

Commercial Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!